You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

MammaPrint

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

MammaPrint Value for Pre-menopausal Breast Cancer Patients

Recruiting
  • Breast Cancer
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2022

    Profiling to Help Define Need for Neo-Adjuvant Chemotherapy in

    Recruiting
    • Breast Cancer
    • GEP
    • Jette, Brussel, Belgium
      Universitair Ziekenhuis Brussel
    Dec 16, 2022

    Female Breast Cancer Trial in Germany

    Recruiting
    • Female Breast Cancer
      • Moenchengladbach, NRW, Germany
      • +4 more
      Mar 30, 2023

      Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, HER2-Negative Breast Carcinoma Trial in

      Not yet recruiting
      • Anatomic Stage II Breast Cancer AJCC v8
      • +3 more
      • Biospecimen Collection
      • +7 more
      • Portland, Oregon
        SWOG
      Sep 27, 2023

      Breast Cancer Trial in Baltimore (Tamoxifen Citrate, Letrozole, Exemestane)

      Recruiting
      • Breast Cancer
      • Tamoxifen Citrate
      • +4 more
      • Baltimore, Maryland
        Johns Hopkins Bayview Hospital
      Nov 30, 2021

      Breast Cancer Trial in Greece, Israel, United States (MammaPrint, BluePrint, and Full-Genome Testing)

      Recruiting
      • Breast Cancer
      • MammaPrint, BluePrint, and Full-Genome Testing
      • Birmingham, Alabama
      • +117 more
      Dec 1, 2022

      Breast Cancer Trial in Seoul (Leuprorelin acetate, Letrozole, MammaPrint)

      Recruiting
      • Breast Cancer
      • Leuprorelin acetate
      • +2 more
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Mar 11, 2021

      Molecular Typing and Neoadjuvant Chemotherapy in Breast Cancer

      Unknown status
      • Evaluation of the Value of Mammaprint Test Gene Variation in the Prediction of Neoadjuvant Chemotherapy for Breast Cancer
      • neoadjuvant chemotherapy
      • Hangzhou, Zhejiang, China
        Zhejiang Cancer Hospital
      Feb 10, 2020

      MammaPrint on Adjuvant Treatment in Hormone Receptor-positive

      Completed
      • Breast Cancer
      • MammaPrint
      • +2 more
      • Innsbruck, Austria
      • +2 more
      Aug 12, 2019

      NBRST: Prospective Neo-adjuvant REGISTRY Trial

      Completed
      • Breast Cancer
      • MammaPrint 70-gene expression profile
      • BluePrint 80 gene expression profile
      • Glendale, Arizona
      • +75 more
      Jan 14, 2021

      Panels (70-gene Assay) in Chinese Breast Cancer Patients

      Completed
      • Chinese
        • New York, New York
          Columbia University Medical Center
        Jul 1, 2019

        HER2-low in Metastatic Breast Cancer Patients

        Not yet recruiting
        • HER2-negative
          • (no location specified)
          Nov 9, 2023

          PREDICT Version 2.2 of Indian Women With Operable Breast Cancer

          Active, not recruiting
          • Operable Breast Neoplasms
          • prediction of overall survival using Web based PREDICTV2.0 portal
          • Mumbai, Maharashtra, India
            Tata Memorial Hospital
          Apr 28, 2022

          Breast Cancer Trial in Amsterdam (anthracycline-based, docetaxel and capecitabine, tamoxifen)

          Completed
          • Breast Cancer
          • Amsterdam, Netherlands
            Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital
          Nov 16, 2022

          Breast Cancer Trial in Taipei City (PET/MR)

          Recruiting
          • Breast Cancer
          • PET/MR
          • Taipei City, Taiwan
            Department of Radiology,Taipei Veterans General Hospital
          Jul 18, 2022

          Inflammatory Breast Cancer, Stage IIA Breast Cancer, Stage IIIA Breast Cancer Trial in Duarte, South Pasadena (carboplatin,

          Active, not recruiting
          • Inflammatory Breast Cancer
          • +9 more
          • Duarte, California
          • +1 more
          Jul 9, 2021

          Breast Cancer Trial in Shantou (dose-dense nab-paclitaxel followed by EC)

          Recruiting
          • Breast Cancer
          • dose-dense nab-paclitaxel followed by EC
          • Shantou, Guangdong, China
            Shantou Central Hospital
          Feb 4, 2023

          Breast Cancer Trial in United States

          Completed
          • Breast Cancer
            • Palm Springs, California
            • +16 more
            Jun 26, 2018

            Breast Cancer Trial in United States (TAC chemo, TC chemo, Dose Dense AC or FEC100 followed by paclitaxel or docetaxel chemo)

            Completed
            • Breast Cancer
            • TAC chemotherapy
            • +7 more
            • Mobile, Alabama
            • +8 more
            Jun 26, 2018

            18 Gene Classifiers and Oncotype DX (Nanostring)

            Completed
            • Breast Cancer
            • Recurrence
              • Taipei, Taiwan
                Amwise
              Dec 16, 2018

              Breast Tumors Trial in Newnan, Zion (Exemestane, Letrozole, Anastrozole)

              Unknown status
              • Breast Neoplasms
              • Newnan, Georgia
              • +1 more
              Sep 27, 2018

              ER-positive Her2-negative Early Breast Cancer Trial (Genomic test)

              Withdrawn
              • ER-positive Her2-negative Early Breast Cancer
              • Genomic test
              • (no location specified)
              Aug 25, 2017

              Using Symphony in Treatment Decisions Concerning Adjuvant

              Completed
              • Breastcancer
              • Invasive Breast Carcinoma by Gene Expression Profile
                • Den Bosch, Brabant, Netherlands
                • +33 more
                Feb 14, 2017

                MammaPrint in Patients With an Intermediate Recurrence Score

                Completed
                • Hormone Receptor Positive Malignant Neoplasm of Breast
                • MammaPrint
                • Phoenix, Arizona
                • +52 more
                Jan 28, 2016

                Validation of 70-gene MammaPrint Profile in Japanese Population

                Completed
                • Breast Cancer
                  • Osaka, Japan
                    Osaka Medical Center for Cancer and Cadiovascular Diseases
                  Jun 22, 2015